Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Glabros Pharma AB
AB
Active
Org 5594535949
Skaragatan 10 G
Business and other management consultancy activities · NACE 7020
Est. 2023
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1,1M
EBITDA margin
21.0%
Equity ratio
24.9%
Financial strength
Net profit 2024
SEK 188K
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
SEK 1,1M
—
EBITDA
SEK 237K
—
Net profit
SEK 188K
—
Total assets
SEK 858K
—
Equity
SEK 213K
—
Employees
—
—
Company information
Legal name
Glabros Pharma AB
Org number
5594535949
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
23 oktober 2023
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom hälso- och sjukvård, farmaci och life science industrin.
Contact
Address
Skaragatan 10 G
Email
goran.khodayari@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Mölndal
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
1 131
Staff expenses
−766
EBITDA
237
Depreciation & amort.
—
EBIT
237
Net financials
—
Profit before tax
237
Tax
−49
Net profit
188
Balance sheet
SEK thousands
Item
2024
Total assets
858
Equity
213
Long-term debt
—
Short-term debt
645
Total debt
645
Financial ratios
5-year trend
EBITDA margin
21.0%
This company
15.8%
Market median
+33% vs market
2024
2024
Equity ratio
24.9%
This company
38.2%
Market median
-35% vs market
2024
2024
Return on equity
88.3%
This company
18.4%
Market median
+380% vs market
2024
2024
Net profit margin
16.6%
This company
8.1%
Market median
+105% vs market
2024
2024
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
2024
2024
Debt / equity
3.02×
This company
0.62×
Market median
-387% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-23 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AK
Ahmad Khodayari
Deputy Board Member
2023
GK
Goran Khayam Khodayari
Board of Directors
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Glabros Pharma AB also hold positions in
0
other companies.
Person
Role here
Other companies
Ahmad Khodayari
Deputy Board Member
0 companies
Goran Khayam Khodayari
Board of Directors
0 companies